The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, BGI Genomics Co's share price is ¥39.20.
BGI Genomics Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥10.23. Hence, BGI Genomics Co's PS Ratio for today is 3.83.
The historical rank and industry rank for BGI Genomics Co's PS Ratio or its related term are showing as below:
SZSE:300676'
s PS Ratio Range Over the Past 10 Years
Min: 3.09 Med: 7.03 Max: 49.88
Current: 3.84
During the past 12 years, BGI Genomics Co's highest PS Ratio was 49.88. The lowest was 3.09. And the median was 7.03.
SZSE:300676's PS Ratio is ranked worse than 56.42% of 218
companies
in the Medical Diagnostics & Research industry
Industry Median: 3.07
vs SZSE:300676: 3.84
BGI Genomics Co Ltd revenue per share has been in decline over the past 3 years.
During the past 12 months, the average Revenue per Share Growth Rate of BGI Genomics Co was -36.10% per year.
During the past 3 years, the average Revenue per Share Growth Rate was -20.50% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 15.40% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 11.60% per year.
During the past 12 years, BGI Genomics Co's highest 3-Year average Revenue per Share Growth Rate was 56.10% per year. The lowest was -32.90% per year. And the median was 13.90% per year.
Back to Basics: PS Ratio
BGI Genomics Co PS Ratio Historical Data
The historical data trend for BGI Genomics Co's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of BGI Genomics Co's PS Ratio
For the Diagnostics & Research subindustry, BGI Genomics Co's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BGI Genomics Co's PS Ratio Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, BGI Genomics Co's PS Ratio distribution charts can be found below:
* The bar in red indicates where BGI Genomics Co's PS Ratio falls into.
BGI Genomics Co PS Ratio Calculation
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
BGI Genomics Co's Share Price of today is ¥39.20. BGI Genomics Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥10.23.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
BGI Genomics Co (SZSE:300676) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
BGI Genomics Co PS Ratio Related Terms
Thank you for viewing the detailed overview of BGI Genomics Co's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
BGI Genomics Co (SZSE:300676) Business Description
BGI Genomics Co Ltd is a China-based company principally engaged in the provision of genomic class diagnosis and research services through the application of biotechnology. It offers its services in various research areas, such as agriculture and food science, cancer research, metagenomics, reproductive health, biomarker discovery, and drug discovery. The company mainly provides services for domestic and overseas academic institutions hospitals, medical institutions and others.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SZSE:300676 has been successfully added to your 